April 26, 2007 |
Texas lawmakers rejected Gov. Rick Perry's anti-cancer vaccine order Wednesday, sending him a bill that blocks state officials from requiring the shots for at least four years. Perry has said he is disappointed but has not indicated whether he will veto the bill. He has 10 days to sign or veto it, or the proposal will become law without his signature. Lawmakers can override a veto with a two-thirds vote. The legislation passed by well over that margin in both chambers. Republican Rep.
CALIFORNIA | LOCAL
May 18, 2006 |
You might never hear of Bill Fenical again. In the years ahead, though, you could owe him some of your good health. Perhaps your life. Fenical probably won't join the ranks of those Communications Age nobles who transform convenience gadgetry and technological gewgaws into inconceivable wealth. Yet this chemist is hot on the trail of discoveries far more tantalizing. William -- "call me Bill" -- Fenical, PhD, is out to cure cancer. Maybe prevent cancer.
May 24, 2005 |
An anti-cancer drug that suppresses the immune system is the first drug that has been shown to alleviate the most devastating effects of scleroderma, a disease of the connective tissues and lungs. Patients taking cyclophosphamide experienced significant improvement in lung function and a reduction in breathlessness. They also reported feeling healthier and more energetic, Dr. Donald P. Tashkin of UCLA told a San Diego meeting of the American Thoracic Society on Monday.
CALIFORNIA | LOCAL
February 26, 2004 |
William Watson doesn't have cancer. But for at least four days last week, nurses at Martin Luther King Jr./Drew Medical Center gave the 46-year-old man a potent anti-cancer drug before they realized the medication was intended for another patient. When the error was discovered, Watson said, a nursing supervisor told him: "I want you to sign this paper saying that this had happened, but it had no effect on you."
October 15, 2002
I understand the anger and frustration felt by Peggy Orenstein (Commentary, Oct. 9) at the fact that breast cancer continues to kill women (and men), but I disagree with some of the points she makes. The death rate from breast cancer has been decreasing at a rate of 2.2% per year since 1991. As an oncologist who treats breast cancer patients and a longtime volunteer for the American Cancer Society, I am convinced that the decreasing breast cancer death rate is the result of increased breast cancer awareness and increased funding for research.
May 31, 2000 |
The run-up in biotechnology stocks during the first three months this year saved tiny Techniclone Corp. from the brink of oblivion. Shares that were trading at 25 cents in December hit $16.63 during trading in March. But as Techniclone stock has since plummeted--along with a general drop in biotech stocks--the future is a bit more complicated for the Tustin developer of cancer treatments.